Tag: Soleo Health

WASHINGTON – CMS plans to primarily focus MAC, RAC and SMRC medical reviews on claims with dates of service outside of the public health emergency, the agency stated in a recent clarification.  CMS stated:  “During the PHE, flexibilities were applied across claim types. For certain DME items, this included the non-enforcement of clinical indications for coverage. Since clinical indications for coverage were not enforced for certain DME items provided during the PHE, once...

FRISCO, Texas – Soleo Health has been awarded Gold Seal of Approval from The Joint Commission for three programs. It has been awarded new accreditations for both home infusion therapy and specialty pharmacy, and re-accreditation for home care – each valid for 36 months. The Gold Seal is a symbol of quality that reflects a health care organization’s commitment to providing safe and quality patient care.  “Our focus on clinical excellence, quality care and patient safety...

FRISCO, Texas, and LOS ANGELES – Soleo Health has announced that its Los Angeles pharmacy location has earned specialty pharmacy accreditation from URAC. By achieving accreditation, the company says it continues to demonstrate its commitment to quality patient-centric care, patient safety, exceptional therapy management programs and improved outcomes. "The Soleo Health Los Angeles URAC accreditations validate the levels of high-quality care and service we bring to patients throughout California,”...

MINNEAPOLIS – Allina Health has partnered with venture capital firm Flare Capital Partners to launch Inbound Health, a new company that enables health systems and health plans to offer hospital-at-home and skilled nursing-at-home programs.  Allina Health and Flare Capital are leading a $20 million fundraising round for Inbound Health to scale successful acute care-at-home programs nationally through their unique partnership model, they say.  “The home hospital programs...

FRISCO, Texas – Soleo Health, a national provider of complex specialty pharmacy services, has ranked eighth on Dallas Business Journal’s eighth annual list of the 50 Fastest-Growing Middle Market Companies across the Dallas-Fort Worth area. “Soleo Health earned a spot in the top 10 based on our organic growth; geographic expansion; increases in therapeutic programs; and the forging of new relationships with pharmaceutical manufacturers, health insurance plans and health systems,...

NORCROSS, Ga. – Virtis Health, a division of Soleo Health, has opened an ambulatory infusion center in the Atlanta area. “The opening of the new Virtis Health Atlanta AIC, combined with Soleo Health’s complex specialty pharmacy services, affords the company yet another opportunity to extend its abilities and clinical expertise to bring highly personalized care to patients and providers alike,” said Jennifer Joiner, RN, VSN, regional vice president. “Since we offer additional...

FRISCO, Texas – Soleo Health has added AMVUTTRA (vutrisiran) to its specialty pharmacy portfolio to treat adults with the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. Soleo Health offers newly FDA-approved AMVUTTRA injections to patients in their homes (after an evaluation and recommendation by the treating physician) or at one of its ambulatory infusion centers (AICs) nationwide. “This marks the fourth therapy Soleo Health now offers from Alnylam Pharmaceuticals’...

HOUSTON – Virtis Health, a division of Soleo Health, a provider of complex specialty pharmacy services, has opened an ambulatory infusion center in Houston near Texas Medical Center. “We are bringing a highly personalized care and service model to patients and providers throughout greater Houston with our new Virtis Health AI,” said Shahram Badrei, regional business leader for Virtis Health Houston. “Since our model brings additional resources and options to patients, providers...

FRISCO, Texas – Soleo Health has been chosen as one of a select few specialty pharmacies to provide Cuvitru, manufactured by Takeda Pharmaceutical Company, to patients nationwide. “Access to Cuvitru rounds out Soleo Health’s comprehensive immunoglobulin (Ig) therapy offering,” said Drew Walk, Soleo Health’s CEO. “With this addition, Soleo Health now offers all FDA-approved Ig therapies available in the marketplace today. We continue to cater to the needs of our...

FRISCO, Texas – Soleo Health, a national provider of complex specialty pharmacy services, has been selected as a limited distribution partner for the cardiovascular drug LEQVIO manufactured by Novartis. “Soleo Health’s expertise in caring for patients with complex conditions and our ability to offer services in the home or alternate sites of care creates additional value for pharmaceutical manufacturers,” said Drew Walk, CEO of Soleo. “We continue to expand our limited...